PE	pulmonary embolism
DVT	deep vein thrombosis
DOACs	direct oral anticoagulants
VTE	venous thromboembolism
FVL	Factor V Leiden
MTHFR	methylenetetrahydrofolate reductase
PAI-1	plasminogen activator inhibitor-1
I/D	insertion/deletion
ACE	angiotensin-converting enzyme
ECG	electrocardiogram
CT	computed tomography
aPTT	activated partial thromboplastin time
HIT	heparin-induced thrombocytopenia
TEA	thromboendarterectomy
tPA	tissue plasminogen activator
F	factor
APS	antiphospholipid syndrome
aPL	antiphospholipid antibody
LAC	lupus anticoagulant
aCL	anticardiolipin antibodies
anti-β2GPI	anti-β2 glycoprotein I antibodies
ACR	American College of Rheumatology
EULAR	European Alliance of Associations for Rheumatology
APC	activated protein C
uPA	urokinase plasminogen activator
4G/5G	guanosine polymorphism
C	cytosine
T	thymine
NO	nitric oxide
ROS	reactive oxygen species
VCAM-1	vascular cell adhesion molecule-1
NF-κB	Nuclear Factor- kappaB
mRNA	messenger ribonucleic acid